CCC, DHC and USAF team up to provide vital aircraft to Guatemala
The Twin Otter Classic 300-G is the latest generation of De Havilland Canada's iconic utility aircraft. Designed for short takeoff and landing (STOL) operations, the aircraft is ideal for reaching remote and hard-to-access regions — a key requirement for humanitarian missions. The Twin Otter is operated by more than 60 military and government organizations worldwide. It has earned a reputation as one of the world's most dependable aircraft, with more than 160 million flight hours to date.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
3 days ago
- Cision Canada
G-P Gia Named a 2025 Top HR Product of the Year by HR Executive
G-P's global HR agent recognized as a cutting-edge technology, delivering real-world impact BOSTON, /CNW/ -- REMOTE FIRST COMPANY -- G-P (Globalization Partners), recognized as the undisputed leader in global employment by industry analysts, today announced Global HR Agent G-P Gia™ has been recognized as a Top HR Product of 2025 by HR Executive. The company will be honored on Monday, September 15, 2025, during the inaugural HR Icons Awards Evening at HR Tech 2025, held at Mandalay Bay in Las Vegas. Judges for the 2025 HR Tech Top Product Awards included Elizabeth Clarke, Executive Editor for HR Executive, Jill Barth, HR Tech Editor for HR Executive and Steve Boese, longtime Top Products judge. In Jill Barth's article on HR Executive, she notes that winners such as G-P Gia "showcase the rise of agentic AI in HR. These tools are now handling complex, multi-step processes that once demanded extensive human involvement." HR Executive also noted Gia was recognized for the following: "We think G-P Gia™ offers HR leaders a practical solution for managing global employment complexities. It streamlines tasks like drafting compliant contracts, comparing multi-state policies and handling performance or termination scenarios across jurisdictions. What sets it apart is its integration of proprietary data with legal and HR expertise, enabling real-time, context-aware guidance. We liked that Gia isn't generic but is built on a specialized framework that reduces errors and adapts to local laws, making it especially useful for teams operating across borders. Its ability to generate documents, flag risks and support multilingual interaction helps HR professionals save time and reduce reliance on external legal counsel." G-P Gia is a first-of-its kind agentic AI solution that is transforming global HR. It empowers HR teams to move faster, operate smarter and achieve global ambitions without being held back by the complexities of global employment. Gia is powered by G-P's proprietary knowledge base and vetted by legal and HR experts to deliver real-time, accurate global employment guidance and actionable HR documents for 50 countries and all 50 U.S. states. Gia dramatically reduces reliance on outside counsel and cuts administrative time and fees by up to 95%. "HR isn't just the backbone of every business, it's a strategic driver of growth, and HR teams need sophisticated agentic technology that empowers them to lead," said Nat Natarajan, chief product and strategy officer, G-P. "G-P Gia isn't just another HR tool or generic AI model – it delivers next-level agentic capabilities and deep insights backed by G-P's proprietary data and G-P's verified sources that empower HR organizations to transform global HR and compliance and drive unparalleled business agility and productivity." The annual Top HR Products competition, organized by HR Executive and HR Tech, is designed to showcase a range of notable solutions introduced over the last year. Reviewed by a panel of esteemed judges, each product submission is evaluated based on its level of innovation, value added to the HR function, overall user experience, ability to deliver on its promises and effective integration, customization and analytics capabilities. The full list of the 2025 award-winning products can be viewed here. Attendees of HR Tech 2025 can learn more about G-P and G-P Gia by visiting Booth No. #4633. About HR Executive Established in 1987, HR Executive is the premier global media company covering strategic issues in HR. Part of the Arc network, HR Executive provides more than 220,000 subscribers with news, content and analysis of global HR trends. HR Executive is where HR professionals go when they need to know, providing in-depth coverage on all facets of human resource management, including recruiting, talent acquisition, compensation and benefits, learning and development, employment law, talent management, the latest technologies and more. Visit About HR Tech HR Tech is the industry's premier event series showcasing breakthrough HR technologies, with its flagship U.S. conference serving as its cornerstone since 1997. HR Tech in the U.S. features the world's largest expo of innovative HR solutions, live product demonstrations and the industry's preeminent startup competition. The HR Tech portfolio has expanded globally with additional annual events in Europe and Asia, creating a worldwide network of innovation hubs that shape the future of work. HR Tech is part of the event arm of HR Executive, a prestigious global media company established in 1987 that delivers news, content and analysis of strategic HR trends to more than 220,000 subscribers worldwide. The synergy between the events and media channels enables the brands to create a comprehensive knowledge ecosystem that addresses all aspects of human resource management, establishing the organization as the definitive authority for visionary HR leaders. Visit to learn more. About G-P G-P (Globalization Partners) is the recognized leader in global employment, ranked No. 1 in every industry analyst report. G-P's global employment platform delivers everything companies of all sizes need to manage the full employee lifecycle with its trusted Global HR Agent, G-P Gia, and AI-powered Employer of Record (EOR) and Contractor products. G-P supports teams in 180+ countries with more than a decade of global employment experience, the largest team of in-country HR, legal, and compliance experts, and its unmatched proprietary knowledge base.
Globe and Mail
06-08-2025
- Globe and Mail
FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y
Fresenius Medical Care AG & Co. FMS reported second-quarter 2025 adjusted earnings per share (EPS) of 52 cents, which surpassed the Zacks Consensus Estimate by 4%. The bottom line improved 36.8% year over year. FMS' Revenue Details Revenues of $5.44 billion (EUR 4,792 million) beat the Zacks Consensus Estimate by 1.6%. The top line increased 1% year over year and 5% at constant currency (cc). Also, revenues were up 7% organically. Per management, during the second quarter, divestitures realized as part of the portfolio optimization plan hurt revenue development by EUR 6 million. The full-year top-line numbers are anticipated to reflect 100 basis points of negative impact due to the portfolio optimization plan in 2024. Shares of FMS gained nearly 2.2% in yesterday's after-market trading. The stock has risen 7.9% year to date against the industry 's decline of 8.8%. The S&P 500 Index has increased 7.4% in the same period. Segmental Details Fresenius Medical implemented a new operating model in 2024 and started reporting under two new segments, Care Delivery and Care Enablement. Care Delivery The segment's revenues were down 3% on a year-over-year basis but up 1% at cc. However, revenues gained 4% on an organic basis. Revenues in the U.S. markets declined 2% reportedly but gained 3% on an organic basis. The top line also improved 3% year over year at cc. Per management, unfavorable exchange rates along with increased mortality due to the severe flu season in the United States in the first months of the year hurt sales in the country. However, this was partially offset by an accelerated number of patient new starts, reimbursement rate increases and a favorable payor mix. Per management, during the first quarter of 2025, U.S. same-market treatment growth remained flat year over year. International sales declined 8% reportedly as well as at cc but gained 5% on an organic basis. The decline was due to divestments realized as part of the portfolio optimization plan, which was partially offset by organic growth. The organic growth was supported by accelerated same-market treatment growth of 1.7%. Care Enablement The segment's revenues decreased 1% year over year reportedly but gained 3% at cc as well as organically. Volume growth and continued positive pricing momentum were offset by unfavorable exchange rate effects. Margin Analysis In the quarter under review, Fresenius Medical's gross profit improved 4.2% year over year. The gross margin expanded 90 basis points (bps) to 25.4%. Selling, general & administrative expenses increased 2.7% on a reported basis. Research and development expenses decreased 17.4% year over year. Adjusted operating income improved 9.2% from the prior-year quarter's level. The adjusted operating margin in the second quarter expanded 80 bps to 9.9%. 2025 Guidance For 2025, Fresenius Medical continues to expect revenue growth to be positive, with a low-single-digit percent rate compared to the prior year. The company also expects operating income to grow by a high-teens to high-twenties percent rate compared to the prior year. Our Take FMS exited the second quarter on a strong note, with its earnings and revenues surpassing their respective consensus estimate. Overall pricing momentum also supported growth in the Care Enablement segment. However, the effects of elevated mortality will likely continue to have a negative impact on sales. Per management, during the first quarter, the FME25 transformation program continued its positive momentum, delivering EUR 58 million additional sustainable savings while related one-time costs, treated as special items, amounted to EUR 53 million. The company confirmed its full-year target of around EUR 180 million in additional annual savings, totaling EUR 1050 million by 2027-end. FMS' continued divestment of its non-core and dilutive assets appears promising, as it will help focus on its core and growing categories, while also boosting its cash resources. FMS' Zacks Rank & Other Stocks to Consider Fresenius Medical currently sports a Zacks Rank #1 (Strong Buy). Some other top-ranked stocks in the broader medical space that have announced quarterly results are Medpace Holdings, Inc. MEDP, West Pharmaceutical Services, Inc. WST and Boston Scientific Corporation BSX. Medpace Holdings, sporting a Zacks Rank of 1 at present, reported second-quarter 2025 EPS of $3.10, which beat the Zacks Consensus Estimate by 3.3%. You can see the complete list of today's Zacks #1 Rank stocks here. Revenues of $603.3 million outpaced the consensus mark by 11.5%. Medpace Holdings has a long-term estimated growth rate of 11.4%. MEDP's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 13.9%. West Pharmaceutical reported second-quarter 2025 adjusted EPS of $1.84, which beat the Zacks Consensus Estimate by 21.9%. Revenues of $766.5 million surpassed the Zacks Consensus Estimate by 5.4%. It currently flaunts a Zacks Rank #1. West Pharmaceutical has a long-term estimated growth rate of 8.5%. WST's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%. Boston Scientific reported second-quarter 2025 adjusted EPS of 75 cents, which beat the Zacks Consensus Estimate by 4.2%. Revenues of $5.06 billion surpassed the Zacks Consensus Estimate by 3.5%. It currently carries a Zacks Rank #2 (Buy). Boston Scientific has a long-term estimated growth rate of 14%. BSX's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 8.1%. Zacks' Research Chief Picks Stock Most Likely to "At Least Double" Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren't winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%. See Our Top Stock to Double (Plus 4 Runners Up) >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX): Free Stock Analysis Report Fresenius Medical Care AG & Co. KGaA (FMS): Free Stock Analysis Report West Pharmaceutical Services, Inc. (WST): Free Stock Analysis Report Medpace Holdings, Inc. (MEDP): Free Stock Analysis Report
Toronto Star
05-08-2025
- Toronto Star
CCC delivers donated Canadian military assistance to Ukraine
OTTAWA, Ontario, Aug. 05, 2025 (GLOBE NEWSWIRE) — CCC is pleased to announce the latest delivery of Canadian military assistance donated by the Department of National Defence (DND) to the government of Ukraine. The donations were manufactured by Colt Canada in Kitchener, Ontario, then shipped by air to Ukraine. As part of the Government of Canada's assistance to Ukraine, CCC is working with DND to provide timely and effective sourcing of military equipment for the Ukrainian government. Since the start of Russia's war on Ukraine, CCC has facilitated the delivery of almost $2 billion of Canadian in-kind aid to Ukraine.
